2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid

Catalog No. :
ACRHLD483
CAS No. :
156478-71-6
Molecular Formula :
C11H20N2O4
Molecular Weight :
244.29

IUPAC Name:2-(4-(tert-butoxycarbonyl)piperazin-1-yl)acetic acid

2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g98%$58.00Login to see priceIn stockInquiry
25g98%$111.00Login to see priceIn stockInquiry
100g98%$417.00Login to see priceIn stockInquiry
500g98%$1459.00Login to see priceIn stockInquiry
1000g98%$2333.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-(tert-Butoxycarbonyl)piperazin-1-yl)acetic acid
IUPAC Name2-(4-(tert-butoxycarbonyl)piperazin-1-yl)acetic acid
MDL No.MFCD02682402
Molecular FormulaC11H20N2O4
Molecular Weight244.29
SMILESO=C(O)CN1CCN(C(OC(C)(C)C)=O)CC1
InChI KeyWZBHMXRBXXCEDD-UHFFFAOYSA-N
SynonymFT-0648141 | 4-Boc-1-piperazineacetic acid | SCHEMBL578032 | MFCD02682402 | 2-(4-BOC-1-PIPERAZINYL)ACETIC ACID | 2-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-ium-1-yl]acetate | WZBHMXRBXXCEDD-UHFFFAOYSA-N | [4-(tert-butoxycarbonyl)-1-piperazinyl]ace
CAS No.156478-71-6
PubChem CID2735642

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRHLD483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNZCE271 route compound structure diagram
    ACNZCE271209667-59-4 In Stock
  2. Then
  3. ACRHLD483 route product structure diagram
    ACRHLD483156478-71-6 In Stock
Inquiry

2. ACRHLD483 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRHLD483 route product structure diagram
    ACRHLD483156478-71-6 In Stock
Inquiry

Comments (0)